Steris Corporation (STE) - Financial and Strategic SWOT Analysis Review

Date: August 4, 2015
Pages: 54
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SA4E1C3D1D3EN
Leaflet:

Download PDF Leaflet

Steris Corporation (STE) - Financial and Strategic SWOT Analysis Review
Steris Corporation (STE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Steris Corporation (Steris), formerly Innovative Medical Technologies is a medical devices company. It specializes in the development, manufacture, and marketing of infection prevention, contamination control, microbial reduction, and surgical and critical care products and support services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers. The company's product portfolio includes capital equipment, connectivity solutions, and consumable products. It also offers a wide range of support services such as equipment installation and maintenance; microbial reduction of medical devices, instrument and Scope repair solutions, and laboratory testing services. Steris has manufacturing facilities in the US, Canada, Brazil, Mexico, China, and European countries. The company operates in over 60 countries through a network of direct sales force and a service organization. Steris is headquartered in Mentor, Ohio, the US.

Steris Corporation Key Recent Developments

May 07, 2015: STERIS Announces Fiscal 2015 Fourth Quarter and Full Year Financial Results
May 07, 2015: STERIS Corporation Announces Fiscal 2015 Fourth Quarter and Full Year Financial Results
Feb 04, 2015: STERIS Announces Fiscal 2015 Third Quarter Results
Oct 15, 2013: STERIS to Announce Fiscal 2014 Second Quarter Financial Results on October 30, 2013
Aug 07, 2013: STERIS Corporation Announces Fiscal 2014 First Quarter Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Steris Corporation - Key Facts
Steris Corporation - Key Employees
Steris Corporation - Key Employee Biographies
Steris Corporation - Major Products and Services
Steris Corporation - History
Steris Corporation - Company Statement
Steris Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Steris Corporation - Key Manufacturing Facilities

SECTION 2 – COMPANY ANALYSIS

Steris Corporation - Business Description
Business Description - Healthcare
Healthcare - Overview
Healthcare - Financials
Business Description - Life Sciences
Life Sciences - Overview
Life Sciences - Financials
Business Description - STERIS Isomedix Services
STERIS Isomedix Services - Overview
STERIS Isomedix Services - Financials
Steris Corporation - Corporate Strategy
Steris Corporation - SWOT Analysis
SWOT Analysis - Overview
Steris Corporation - Strengths
Strength - Healthcare Franchise
Strength - Strong Research and Development Capabilities
Strength - Extensive Manufacturing Facilities
Steris Corporation - Weaknesses
Weakness - Lack of Geographical Diversification
Weakness - Warning Letters
Weakness - Product Safety Concerns
Steris Corporation - Opportunities
Opportunity - Product Innovation
Opportunity - Market Prospects: Cleaning and Sanitizing Equipment Market
Opportunity - Business Combination
Steris Corporation - Threats
Threat - Competitive Landscape
Threat - Extensive Regulations
Threat - Stringent Reimbursement Policies
Steris Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Steris Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Steris Corporation, Medical Equipment, Deals By Type, 2009 to YTD 2015
Steris Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 07, 2015: STERIS Announces Fiscal 2015 Fourth Quarter and Full Year Financial Results
May 07, 2015: Clinical study results demonstrate that the iSnare system may be superior in the removal of large, flat polyps
Feb 17, 2015: Clinical study results demonstrate advantages of cold polypectomy with the US Endoscopy Exacto cold snare
Feb 04, 2015: STERIS Announces Fiscal 2015 Third Quarter Results
Jan 27, 2015: US Endoscopy announces full market release of the Roth Net retriever – mini polyp
Dec 03, 2014: US Endoscopy recognizes Dr. David L. Carr-Locke for 1 million needles sold
Nov 04, 2014: STERIS Announces Fiscal 2015 Second Quarter Results
Aug 05, 2014: STERIS Announces Fiscal 2015 First Quarter Results
Jul 22, 2014: US Endoscopy announces full market release of the Torrent irrigation scope connector – Pentax
May 08, 2014: STERIS Announces Fiscal 2014 Fourth Quarter and Full Year Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Steris Corporation, Key Facts
Steris Corporation, Key Employees
Steris Corporation, Key Employee Biographies
Steris Corporation, Major Products and Services
Steris Corporation, History
Steris Corporation, Other Locations
Steris Corporation, Subsidiaries
Steris Corporation, Key Manufacturing Facilities
Steris Corporation, Key Competitors
Steris Corporation, Ratios based on current share price
Steris Corporation, Annual Ratios
Steris Corporation, Interim Ratios
Steris Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Steris Corporation, Medical Equipment, Deals By Type, 2009 to YTD 2015
Steris Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Steris Corporation, Performance Chart (2011 - 2015)
Steris Corporation, Ratio Charts
Steris Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Steris Corporation, Medical Equipment, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Steris Corporation (STE) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: